Compare IVR & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVR | PSNL |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 708.6M | 729.1M |
| IPO Year | N/A | 2019 |
| Metric | IVR | PSNL |
|---|---|---|
| Price | $8.33 | $5.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $8.25 | ★ $12.20 |
| AVG Volume (30 Days) | ★ 2.0M | 1.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 17.80% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $150.63 | $15.34 |
| Revenue Next Year | N/A | $41.46 |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.10 | $3.84 |
| 52 Week High | $9.50 | $11.50 |
| Indicator | IVR | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 40.10 |
| Support Level | $8.26 | $4.65 |
| Resistance Level | $8.44 | $6.99 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 65.56 | 34.29 |
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.